We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Diatron Presents High-Quality Hematology and Clinical Chemistry Products

By LabMedica International staff writers
Posted on 29 Jul 2025

Diatron (Budapest, Hungary) is exhibiting at ADLM 2025, where the company is presenting its newly launched clinical chemistry analyzer alongside other high-quality hematology products. More...

Diatron’s new clinical chemistry analyzer, the P780, which is being introduced at the show, is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories. Ideal for a variety of lab sizes, from medium to large, the P780 is engineered for high reliability, offering an innovative and scalable solution. As Diatron’s flagship clinical chemistry analyzer, the P780 excels in maximum throughput, which is enabled by uninterrupted photometric tests and an independent ISE arm. As a result, the P780 allows continuous operation under demanding workloads, ensuring fast turnaround times without compromising accuracy. The system is equipped with a dual concentric reagent tray with cooled positions for calibrators and controls, plus an optional Auto Filling Draining Module that enables nonstop operation and reduces manual work.

A built-in panel PC with a touchscreen interface helps to minimize the instrument’s footprint and streamline daily use. The system features advanced software, delivering an intuitive, easy-to-use interface and a comprehensive dashboard, with real-time worklist monitoring and flexible workflow management tools to simplify daily lab procedures. Diatron is also showcasing Aquila, its innovative and revolutionary 3-part differential hematology analyzer that can be used in any testing location and application where high-quality CBC results are desired. The company’s latest technology offers the optimal testing solution for both the experienced and inexperienced user, and practices that require a high-quality hematology analyzer.

Diatron is also highlighting its Aquarius 3 hematology analyzer that combines technology and simplicity to give all the required information, reducing the unnecessary steps to a minimum whilst maintaining the balance between cost and benefit for patients and users alike. With a sleek, new modern design, the Aquarius 3 interface offers a positive touch and feeling, with all actions designed to increase efficiency, saving time to perform other important tasks. The new Aquarius 3 software features a high level of patient management and workflow optimization to avoid repetition whilst only having a small reagent consumption.

Related Links:
Diatron


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HPV Test
Allplex HPV28 Detection
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.